We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,756 hedge funds and large institutions have $252B invested in Johnson & Johnson in 2019 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 1,129 increasing their positions, 1,289 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 66

4.93% more ownership

Funds ownership: 68.05%72.98% (+4.9%)

0% less funds holding

Funds holding: 2,7662,756 (-10)

0% less capital invested

Capital invested by funds: $253B → $252B (-$1.14B)

7% less funds holding in top 10

Funds holding in top 10: 690639 (-51)

11% less call options, than puts

Call options by funds: $1.69B | Put options by funds: $1.9B

12% less repeat investments, than reductions

Existing positions increased: 1,129 | Existing positions reduced: 1,289

Holders
2,756
Holders Change
-10
Holders Change %
-0.36%
% of All Funds
59.85%
Holding in Top 10
639
Holding in Top 10 Change
-51
Holding in Top 10 Change %
-7.39%
% of All Funds
13.88%
New
91
Increased
1,129
Reduced
1,289
Closed
66
Calls
$1.69B
Puts
$1.9B
Net Calls
-$208M
Net Calls Change
+$260M
Name Holding Trade Value Shares
Change
Change in
Stake
GCC
426
Guardian Capital (Canada)
Ontario, Canada
$29.6M -$610K -4,404 -2%
PA
427
Pinnacle Associates
New York
$29.6M -$32.1K -232 -0.1%
CC
428
Cannell & Co
New York
$29.4M -$332K -2,395 -1%
PFM
429
Parsec Financial Management
North Carolina
$29.4M +$2.01M +14,534 +7%
TAM
430
Tiverton Asset Management
Delaware
$29.3M +$4.99M +36,041 +21%
MNBTD
431
Moody National Bank Trust Division
Texas
$29.3M +$54.1K +391 +0.2%
Millennium Management
432
Millennium Management
New York
$29.3M -$49.2M -355,518 -63%
NP
433
NS Partners
United Kingdom
$29.1M +$173K +1,253 +0.6%
CAM
434
Cidel Asset Management
Ontario, Canada
$29.1M +$413K +2,986 +1%
LIC
435
Lodestar Investment Counsel
Illinois
$29.1M -$190K -1,370 -0.7%
PCIG
436
Partners Capital Investment Group
Massachusetts
$29M -$1.03M -7,418 -3%
CBUSF
437
Construction & Building Unions Superannuation Fund
Australia
$29M
DCM
438
Donaldson Capital Management
Indiana
$29M +$355K +2,567 +1%
DWM
439
Destination Wealth Management
California
$28.8M -$201K -1,453 -0.7%
CSS
440
Cubist Systematic Strategies
Connecticut
$28.8M +$23.5M +170,030 +461%
SCI
441
S&CO Inc
Massachusetts
$28.8M -$54.8K -396 -0.2%
ADEF
442
Adams Diversified Equity Fund
Maryland
$28.5M +$9.29M +67,100 +49%
ANI
443
American National Insurance
Texas
$28.5M
PP
444
Palladium Partners
Virginia
$28.4M +$16.2K +117 +0.1%
CTB
445
Country Trust Bank
Illinois
$28.2M -$139K -1,007 -0.5%
RCM
446
Riverhead Capital Management
Delaware
$28.2M +$8.52M +61,549 +44%
CAPTRUST Financial Advisors
447
CAPTRUST Financial Advisors
North Carolina
$28.1M +$3.89M +28,079 +16%
CTA
448
Chesley Taft & Associates
Illinois
$28M -$1.66K -12 -0%
WG
449
Welch Group
Alabama
$28M -$217K -1,565 -0.8%
TBA
450
Tower Bridge Advisors
Pennsylvania
$28M +$229K +1,651 +0.8%

JNJ Hedge Fund Activity: Q2 2019 in Review

2,756 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2019, worth a combined $252B — down 0.45% from $253B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new JNJ positions and 66 closed out — a net gain of 25 holders — while 1,129 added to existing stakes and 1,289 trimmed.

The largest buyer was Phocas Financial Corp, adding an estimated $17.3B. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $719M.

  • 2,756 institutional investors held Johnson & Johnson (JNJ) as of Q2 2019, down from 2,766 in Q1 2019.
  • Funds reported $252B of Johnson & Johnson stock for Q2 2019, down 0.45% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q2 2019 and 66 closed out, a net change of +25 holders.
  • The largest Johnson & Johnson buyer in Q2 2019 was Phocas Financial Corp, an estimated $17.3B added.
  • The largest Johnson & Johnson seller in Q2 2019 was Barrow, Hanley, Mewhinney & Strauss, an estimated $719M sold.

Based on aggregated 13F filings for Q2 2019.